Home Cart Sign in  
Chemical Structure| 147084-10-4 Chemical Structure| 147084-10-4

Structure of Alcaftadine
CAS No.: 147084-10-4

Chemical Structure| 147084-10-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alcaftadine is a high affinity ligand for the H1 receptor, with a pKi (8.5) that is comparable with that of other H1 antihistamines.

Synonyms: R89674; Lastacaft

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alcaftadine

CAS No. :147084-10-4
Formula : C19H21N3O
M.W : 307.39
SMILES Code : O=CC1=CN=C2N1CCC3=CC=CC=C3/C2=C4CCN(C)CC\4
Synonyms :
R89674; Lastacaft
MDL No. :MFCD09954106
InChI Key :MWTBKTRZPHJQLH-UHFFFAOYSA-N
Pubchem ID :19371515

Safety of Alcaftadine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Alcaftadine

GPCR

Isoform Comparison

Biological Activity

Target
  • H2 receptor

    H2 receptor, pKi:7.2

  • H1 receptor

    H1 receptor, pKi:8.5

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01390961 Allergic Conjunctivitis Phase 4 Unknown January 2012 United States, California ... More >> Milton M. Hom, OD, FAAO. Azusa, California, United States, 91702 Less <<
NCT00889330 Allergic Conjunctivitis Phase 3 Completed - United States, Ohio ... More >> Fairfield, Ohio, United States Mason, Ohio, United States Less <<
NCT00889330 - Completed - -
NCT02308501 Allergic Conjunctivitis Phase 4 Completed - -
NCT01470118 Conjunctivitis, Allergic Phase 4 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States Less <<
NCT01732757 Conjunctivitis, Allergic Phase 4 Completed - United States, Tennessee ... More >> Memphis, Tennessee, United States Less <<
NCT01470118 - Completed - -
NCT01339507 - Completed - United States, Texas ... More >> Derek Cunningham Austin, Texas, United States, 78746 Less <<
NCT01732757 - Completed - -
NCT02555761 - Completed - -
NCT01808768 Allergic Conjunctivitis|Rhinoc... More >>onjunctivitis Less << PHASE4 UNKNOWN 2025-11-13 STARx Research Center, Edison,... More >> New Jersey, 08820, United States|STARx, Springfield, New Jersey, 07081, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.27mL

3.25mL

1.63mL

32.53mL

6.51mL

3.25mL

References

 

Historical Records

Categories